Actively Recruiting
Alcohol Research in HIV: Relapse Prevention
Led by Johns Hopkins University · Updated on 2026-02-18
150
Participants Needed
1
Research Sites
218 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins University
Lead Sponsor
N
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.
CONDITIONS
Official Title
Alcohol Research in HIV: Relapse Prevention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of HIV
- Age 18 years or older
- Currently enrolled in clinical care at Johns Hopkins HIV Clinic
- Lifetime diagnosis of alcohol use disorder
- Patient-reported outcomes showing, within the last 3 years, periods of no or lower risk drinking and periods of lapse to higher levels of drinking
- Current patient-reported outcomes showing alcohol abstinence or alcohol use below 11 drinks/week for women or 22 drinks/week for men
You will not qualify if you...
- Acutely suicidal, homicidal, psychotic, or unable to provide informed consent
- Non-English speaking (interventions available only in English)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Johns Hopkins School of Medicine
Baltimore, Maryland, United States, 21287
Actively Recruiting
Research Team
H
Heidi Hutton, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here